1,377
Views
56
CrossRef citations to date
0
Altmetric
Review Article

Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine

, , &
Pages 470-519 | Received 29 May 2015, Accepted 08 Sep 2015, Published online: 16 Nov 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rosemary H. Waring. (2020) Cytochrome P450: genotype to phenotype. Xenobiotica 50:1, pages 9-18.
Read now
Mohamad M. Kronfol, Mikhail G. Dozmorov, Rong Huang, Patricia W. Slattum & Joseph L. McClay. (2017) The role of epigenomics in personalized medicine. Expert Review of Precision Medicine and Drug Development 2:1, pages 33-45.
Read now

Articles from other publishers (54)

Huiqiong Zou, Yingying Cao, Peipei Hao, Ziqi Jin, Ruifeng Ding, Xuefeng Bai, Kun Zhang & Yongzhi Xue. (2023) New insights into the downregulation of cytochrome P450 2E1 via nuclear factor κB-dependent pathways in immune-mediated liver injury. Heliyon 9:12, pages e22641.
Crossref
Huiqiong Zou, Peipei Hao, Yingying Cao, Li Li, Ruifeng Ding, Xuefeng Bai & Yongzhi Xue. (2023) Hippophae rhamnoides reverses decreased CYP2D6 expression in rats with BCG-induced liver injury. Scientific Reports 13:1.
Crossref
Shiyao Gu, Qingyong Luo, Cen Wen, Yu Zhang, Li Liu, Liu Liu, Su Liu, Chunhua Chen, Qian Lei & Si Zeng. (2023) Application of Advanced Technologies—Nanotechnology, Genomics Technology, and 3D Printing Technology—In Precision Anesthesia: A Comprehensive Narrative Review. Pharmaceutics 15:9, pages 2289.
Crossref
Javier Muriel, Jordi Barrachina, Guillermo Del Barco, Cristian Carvajal, Mónica Escorial, César Margarit, Pura Ballester & Ana María Peiró. (2023) Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences. Frontiers in Pharmacology 14.
Crossref
Beatriz Orts Jorquera, Javier Muriel Serrano & Ana María Peiró Peiró. (2023) Farmacogenética y respuesta analgésica: hacia una medicina personalizada con análisis de las diferencias por sexo. Revista de la Sociedad Española del Dolor.
Crossref
Tanmoy Mondal, Christopher A. Loffredo, Jyothirmai Simhadri, Gail Nunlee‐Bland, Brent Korba, Jheannelle Johnson, Sharleine Cotin, Gemeyel Moses, Ruth Quartey, Charles D. Howell, Zarish Noreen, Maria Arif & Somiranjan Ghosh. (2022) Insights on the pathogenesis of type 2 diabetes as revealed by signature genomic classifiers in an African American population in the Washington, DC area. Diabetes/Metabolism Research and Reviews 39:1.
Crossref
M. V. Miroshnikov, K. T. Sultanova, M. N. Makarova & V. G. Makarov. (2022) A comparative review of the activity of enzymes of the cytochrome P450 system in humans and laboratory animals. Prognostic value of preclinical models in vivo. Translational Medicine 9:5, pages 44-77.
Crossref
Médéric Mouterde, Youssef Daali, Victoria Rollason, Martina Čížková, Anwar Mulugeta, Khalid A Al Balushi, Giannoulis Fakis, Theodoros C Constantinidis, Khalid Al-Thihli, Marie Černá, Eyasu Makonnen, Sotiria Boukouvala, Said Al-Yahyaee, Getnet Yimer, Viktor Černý, Jules Desmeules & Estella S Poloni. (2022) Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in Humans. Genome Biology and Evolution 14:12.
Crossref
Navid Neyshaburinezhad, Hengameh Ghasim, Mohammadreza Rouini, Youssef Daali & Yalda H. Ardakani. (2022) Variations in the Frequencies of Polymorphisms in the CYP450s Genes in Eight Major Ethnicities of Iran: A Review of the Human Data. Journal of Personalized Medicine 12:11, pages 1848.
Crossref
Yagmur Tasdemiroglu, Robert G. Gourdie & Jia-Qiang He. (2022) In vivo degradation forms, anti-degradation strategies, and clinical applications of therapeutic peptides in non-infectious chronic diseases. European Journal of Pharmacology 932, pages 175192.
Crossref
Jaiana L. M. Cardoso, Yanka E. A. R. Salazar, Anne C. G. Almeida, Laila R. A. Barbosa, Emanuelle L. Silva, Maria Gabriela Almeida Rodrigues, Fernanda Rodrigues-Soares, Vanderson S. Sampaio, André M. Siqueira, Marcus V. G. Lacerda, Wuelton M. Monteiro & Gisely C. Melo. (2022) Influence of CYP2D6, CYP3A4 and CYP2C19 Genotypes on Recurrence of Plasmodium vivax. Frontiers in Tropical Diseases 3.
Crossref
Anita Stojanović Marković, Matea Zajc Petranović, Željka Tomas, Borna Puljko, Maja Šetinc, Tatjana Škarić-Jurić & Marijana Peričić Salihović. (2022) Untangling SNP Variations within CYP2D6 Gene in Croatian Roma. Journal of Personalized Medicine 12:3, pages 374.
Crossref
Emine DIRAMAN. (2022) Karaciğerde Detoksifikasyon. European Journal of Science and Technology.
Crossref
Anja Stajnko, Agneta Annika Runkel, Tina Kosjek, Janja Snoj Tratnik, Darja Mazej, Ingrid Falnoga & Milena Horvat. (2022) Assessment of susceptibility to phthalate and DINCH exposure through CYP and UGT single nucleotide polymorphisms. Environment International 159, pages 107046.
Crossref
Mongi Benjeddou & Ana M. Peiró. 2022. The Neurobiology, Physiology, and Psychology of Pain. The Neurobiology, Physiology, and Psychology of Pain 45 56 .
James Akingbasote, Sandra Szlapinski, Elora Hilmas, Patrik Miller & Natalie Rine. 2022. Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology. Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology 197 232 .
Fuguo Cao, Zhongxing Li, Lijuan Jiang, Chen Liu, Qian Qian, Feng Yang, Fengwang Ma & Qingmei Guan. (2021) Genome-wide association study (GWAS) of leaf wax components of apple. Stress Biology 1:1.
Crossref
K. Darney, L.S. Lautz, C. Béchaux, W. Wiecek, E. Testai, B. Amzal & J.L.C.M. Dorne. (2021) Human variability in polymorphic CYP2D6 metabolism: Implications for the risk assessment of chemicals in food and emerging designer drugs. Environment International 156, pages 106760.
Crossref
Navid Neyshaburinezhad, Hengameh Ghasim, Mohammadreza Rouini, Youssef Daali & Yalda H. Ardakani. (2021) Frequency of Important CYP450 Enzyme Gene Polymorphisms in the Iranian Population in Comparison with Other Major Populations: A Comprehensive Review of the Human Data. Journal of Personalized Medicine 11:8, pages 804.
Crossref
Maaike van der Lee, William G. AllardRolf H. A. M. VossenRenée F. Baak-PabloRoberta Menafra, Birgit A. L. M. Deiman, Maarten J. Deenen, Patrick NevenInger JohanssonStefano Gastaldello, Magnus Ingelman-SundbergHenk-Jan Guchelaar, Jesse J. Swen & Seyed Yahya Anvar. (2021) Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data . Science Translational Medicine 13:603.
Crossref
Lei Feng, Jing Ning, Xiangge Tian, Chao Wang, Zhenlong Yu, Xiaokui Huo, Tian Xie, Baojing Zhang, Tony D. James & Xiaochi Ma. (2021) Fluorescent probes for the detection and imaging of Cytochrome P450. Coordination Chemistry Reviews 437, pages 213740.
Crossref
Anna Colombo, Francesca Giordano, Federica Giorgetti, Ilaria Di Bernardo, Monica F. Bosi, Alberto Varinelli, Rita Cafaro, Paola Pileri, Irene Cetin, Emilio Clementi, Caterina A. Viganò & Bernardo Dell'Osso. (2020) Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: Results from a naturalistic study in patients with affective disorders. Human Psychopharmacology: Clinical and Experimental 36:3.
Crossref
Nenad Neskovic, Dario Mandic, Saska Marczi, Sonja Skiljic, Gordana Kristek, Hrvoje Vinkovic, Boris Mraovic, Zeljko Debeljak & Slavica Kvolik. (2021) Different Pharmacokinetics of Tramadol, O-Demethyltramadol and N-Demethyltramadol in Postoperative Surgical Patients From Those Observed in Medical Patients. Frontiers in Pharmacology 12.
Crossref
Emanuela Testai, Camille Bechaux, Franca M. Buratti, Keyvin Darney, Emma Di Consiglio, Emma E.J. Kasteel, Nynke I. Kramer, Leonie S. Lautz, Nicoletta Santori, Zoi‐Vasiliki Skaperda, Dimitrios Kouretas, Laura Turco & Susanna Vichi. (2021) Modelling human variability in toxicokinetic and toxicodynamic processes using Bayesian meta‐analysis, physiologically‐based modelling and in vitro systems. EFSA Supporting Publications 18:4.
Crossref
Tawit Suriyo, Sadudee Chotirat, Nuchanart Rangkadilok, Nanthanit Pholphana & Jutamaad Satayavivad. (2021) Interactive effects of Andrographis paniculata extracts and cancer chemotherapeutic 5-Fluorouracil on cytochrome P450s expression in human hepatocellular carcinoma HepG2 cells. Journal of Herbal Medicine 26, pages 100421.
Crossref
Alia A. Sagatova. (2021) Strategies to Better Target Fungal Squalene Monooxygenase. Journal of Fungi 7:1, pages 49.
Crossref
Trine Frederiksen, Johan Areberg, Ellen Schmidt, Tore Bjerregaard Stage & Kim Brøsen. (2020) Quantification of In Vivo Metabolic Activity of CYP2D6 Genotypes and Alleles Through Population Pharmacokinetic Analysis of Vortioxetine . Clinical Pharmacology & Therapeutics 109:1, pages 150-159.
Crossref
Laura López de Frutos, Pilar Alfonso, Carlos Lahoz, Pilar Irún & Pilar Giraldo. (2020) Allelic and phenotypic characterization of CYP2D6 and its encoded P450 cytochrome enzyme in a serie of Spanish type 1 Gaucher disease patients. Medicina Clínica 155:12, pages 529-534.
Crossref
Laura López de Frutos, Pilar Alfonso, Carlos Lahoz, Pilar Irún & Pilar Giraldo. (2020) Allelic and phenotypic characterization of CYP2D6 and its encoded P450 cytochrome enzyme in a serie of Spanish type 1 Gaucher disease patients. Medicina Clínica (English Edition) 155:12, pages 529-534.
Crossref
Jesus Fernandez-Abascal, Elda Chiaino, Maria Frosini, Gavin P. Davey & Massimo Valoti. (2020) β-Naphthoflavone and Ethanol Reverse Mitochondrial Dysfunction in A Parkinsonian Model of Neurodegeneration. International Journal of Molecular Sciences 21:11, pages 3955.
Crossref
Andrea Fanelli, Chiara Palazzo, Eleonora Balzani, Alessandra Iuvaro, Susi Pelotti & Rita Maria Melotti. (2020) An Explorative Study of CYP2D6’s Polymorphism in a Sample of Chronic Pain Patients. Pain Medicine 21:5, pages 1010-1017.
Crossref
Muslih Abdulkarim Ibrahim, Zalina Zahari, Nurfadhlina Musa & Khoo Boon Yin. (2020) Genetic Polymorphisms of CYP2D6: Prevalence in Healthy Kurds. Current Pharmacogenomics and Personalized Medicine 17:1, pages 40-47.
Crossref
Gustav Kamenski, Seda Ayazseven, Anne Berndt, Waltraud Fink, Lukas Kamenski, Sonja Zehetmayer & Helene Pühringer. (2019) Clinical Relevance of CYP2D6 Polymorphisms in Patients of an Austrian Medical Practice: A Family Practice-Based Observational Study. Drugs - Real World Outcomes 7:1, pages 63-73.
Crossref
Luciana P. C. Leitão, Tatiane P. Souza, Juliana C. G. Rodrigues, Marianne R. Fernandes, Sidney Santos & Ney P. C. Santos. (2020) The Metabolization Profile of the CYP2D6 Gene in Amerindian Populations: A Review. Genes 11:3, pages 262.
Crossref
Michael D. Coleman. 2020. Human Drug Metabolism. Human Drug Metabolism 37 107 .
Vimal M. Aga, Mujeeb U. Shad, Hongru Zhu & Carl Salzman. 2020. Handbook of Mental Health and Aging. Handbook of Mental Health and Aging 315 399 .
Clarissa Feltrin & Cláudia Maria Oliveira Simões. (2019) Reviewing the mechanisms of natural product-drug interactions involving efflux transporters and metabolic enzymes. Chemico-Biological Interactions 314, pages 108825.
Crossref
Flavia Storelli, Jules Desmeules & Youssef Daali. (2019) Physiologically‐Based Pharmacokinetic Modeling for the Prediction of CYP2D6‐Mediated Gene–Drug–Drug Interactions. CPT: Pharmacometrics & Systems Pharmacology 8:8, pages 567-576.
Crossref
Clarissa Feltrin, Paula Freire Brambila & Cláudia Maria Oliveira Simões. (2019) Development of Caco-2 cells-based gene reporter assays and evaluation of herb-drug interactions involving CYP3A4 and CYP2D6 gene expression. Chemico-Biological Interactions 303, pages 79-89.
Crossref
Abdel B. Halim. 2019. Biomarkers, Diagnostics and Precision Medicine in the Drug Industry. Biomarkers, Diagnostics and Precision Medicine in the Drug Industry 41 74 .
Andrius Baskys. (2018) Application of pharmacogenetics in clinical practice: problems and solutions. Journal of Neural Transmission 126:1, pages 109-113.
Crossref
Miaoran Ning, Julio D. Duarte, Leah H. Rubin & Hyunyoung Jeong. (2018) CYP2D6 Protein Level Is the Major Contributor to Interindividual Variability in CYP2D6‐Mediated Drug Metabolism in Healthy Human Liver Tissue. Clinical Pharmacology & Therapeutics 104:5, pages 974-982.
Crossref
Jesus Fernandez-Abascal, Mariantonia Ripullone, Aurora Valeri, Cosima Leone & Massimo Valoti. (2018) β-Naphtoflavone and Ethanol Induce Cytochrome P450 and Protect towards MPP+ Toxicity in Human Neuroblastoma SH-SY5Y Cells. International Journal of Molecular Sciences 19:11, pages 3369.
Crossref
Ying-Yuan Lu, Zhi-Yong Du, Yan Li, Jin-Long Wang, Ming-Bo Zhao, Yong Jiang, Xiao-Yu Guo & Peng-Fei Tu. (2018) Effects of Baoyuan decoction, a traditional Chinese medicine formula, on the activities and mRNA expression of seven CYP isozymes in rats. Journal of Ethnopharmacology 225, pages 327-335.
Crossref
Philip D. Hansten. (2018) The Underrated Risks of Tamoxifen Drug Interactions. European Journal of Drug Metabolism and Pharmacokinetics 43:5, pages 495-508.
Crossref
Charleen G. Don & Martin Smieško. (2018) Microsecond MD simulations of human CYP2D6 wild-type and five allelic variants reveal mechanistic insights on the function. PLOS ONE 13:8, pages e0202534.
Crossref
Umit Yasar & Melih O. Babaoglu. (2018) Extracorporeal circulation systems in coronary artery bypass surgery can affect pharmacokinetics of drugs: may altered CYP-mediated liver function be a possible reason?. European Journal of Clinical Pharmacology 74:8, pages 1095-1095.
Crossref
Si Chen, Qiangen Wu, Baitang Ning, Matthew Bryant & Lei Guo. (2018) The role of hepatic cytochrome P450s in the cytotoxicity of dronedarone. Archives of Toxicology 92:6, pages 1969-1981.
Crossref
Andrea Gaedigk, Jean Dinh, Hyunyoung Jeong, Bhagwat Prasad & J. Leeder. (2018) Ten Years’ Experience with the CYP2D6 Activity Score: A Perspective on Future Investigations to Improve Clinical Predictions for Precision Therapeutics. Journal of Personalized Medicine 8:2, pages 15.
Crossref
Aleksi Tornio & Janne T. Backman. 2018. Pharmacogenetics. Pharmacogenetics 3 32 .
Mohd Sami ur Rasheed, Abhishek Kumar Mishra & Mahendra Pratap Singh. (2017) Cytochrome P450 2D6 and Parkinson’s Disease: Polymorphism, Metabolic Role, Risk and Protection. Neurochemical Research 42:12, pages 3353-3361.
Crossref
Shuowen Tang, Ang Chen, Xiaojing Zhou, Li Zeng, Mingyao Liu & Xin Wang. (2017) Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay. Toxicology Letters 281, pages 74-83.
Crossref
Heather A. Zierhut, Colleen A. Campbell, Allison G. Mitchell, Amy A. Lemke, Rachel Mills & Jeffrey R. Bishop. (2017) Collaborative Counseling Considerations for Pharmacogenomic Tests. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:9, pages 990-999.
Crossref
Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl-Carrillo, Teri Klein & J. Steven Leeder. (2017) Prediction of CYP2D6 phenotype from genotype across world populations. Genetics in Medicine 19:1, pages 69-76.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.